All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @lalmaseli on TikTok · 10s|Watch on TikTok

Peptide hair serums: what TikTok gets right and wrong

Lalmaseli

TikTok creator

316.5K viewsWatch on TikTok

Quick answer

Topical peptide serums containing GHK-Cu and signal peptides have plausible mechanisms supported by in vitro and small observational studies, but lack large-scale RCT evidence demonstrating clinically meaningful hair regrowth in androgenic alopecia. These products are categorically different from injectable peptide therapies in terms of concentration, bioavailability, and regulatory oversight. Patients with significant hair loss should pursue formal evaluation before relying on OTC serums as a primary intervention.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptide hair serums: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptide hair serums: what TikTok gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptide hair serums: what TikTok gets right and wrong" from Lalmaseli. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Topical peptide serums containing GHK-Cu and signal peptides have plausible mechanisms supported by in vitro and small observational studies, but lack large-scale RCT evidence demonstrating clinically meaningful hair regrowth in androgenic alopecia.

The reason this review is not generic is the source wording and the canonical claim label "peptides 1 the ordinary multi peptide serum the goal density fullness." In this clip, the useful excerpt is: "1." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Ordinary does not disclose the concentration of GHK-Cu in its Multi-Peptide Serum, making direct efficacy comparisons to studied doses impossible.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Topical peptide serums containing GHK-Cu and signal peptides have plausible mechanisms supported by in vitro and small observational studies, but lack large-scale RCT evidence demonstrating clinically meaningful hair regrowth in androgenic alopecia.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Topical peptide serums containing GHK-Cu and signal peptides have plausible mechanisms supported by in vitro and small observational studies, but lack large-scale RCT evidence demonstrating clinically meaningful hair regrowth in androgenic alopecia. These products are categorically different from injectable peptide therapies in terms of concentration, bioavailability, and regulatory oversight. Patients with significant hair loss should pursue formal evaluation before relying on OTC serums as a primary intervention.
  • GHK-Cu (copper tripeptide-1) has real biological plausibility for hair follicle support, but clinical evidence from large RCTs is still missing for OTC topical formulations.
  • The Ordinary does not disclose the concentration of GHK-Cu in its Multi-Peptide Serum, making direct efficacy comparisons to studied doses impossible.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GHK-Cu (copper tripeptide-1) has real biological plausibility for hair follicle support, but clinical evidence from large RCTs is still missing for OTC topical formulations.
  • The Ordinary does not disclose the concentration of GHK-Cu in its Multi-Peptide Serum, making direct efficacy comparisons to studied doses impossible.
  • Aminexil in Kérastase Genesis has modest peer-reviewed support for reducing follicle stiffening, but evidence is largely from small or industry-affiliated studies.
  • Topical peptide serums are not equivalent to injectable peptide therapies like GHK-Cu in clinical protocols; delivery method and concentration change the entire pharmacological picture.
  • Minoxidil remains the most evidence-supported topical hair loss treatment with decades of randomized controlled trial data behind it.
  • Anyone experiencing accelerated shedding, patchy hair loss, or scalp inflammation should see a dermatologist before using any serum as a primary treatment.
  • These products carry low safety risk and reasonable cost, making them acceptable as low-priority adjuncts, but they should not be marketed as clinically proven hair growth solutions.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What's this video probably claiming?

Based on the caption and hashtags, this creator is likely walking through a product recommendation list featuring The Ordinary Multi-Peptide Serum for Hair Density and Kérastase Genesis, framing them as science-backed tools for thinning hair, density loss, and scalp health. The language around "advanced peptide technologies" targeting the hair follicle suggests the video positions these over-the-counter topical products as meaningfully clinical, not just cosmetic. Given the hashtag category ties this content to peptide therapy broadly, including compounds like GHK-Cu, BPC-157, and TB-500, the viewer is likely left with the impression that the peptide mechanisms in a $10 drugstore serum are comparable to prescription-grade peptide interventions. That's a significant leap. The Ordinary's product does contain copper peptides (GHK-Cu) and other signal peptides, but the concentrations, delivery vehicles, and evidence bases are entirely different from injectable or clinically dosed peptide protocols.

What does the science actually show?

GHK-Cu (copper tripeptide-1) is the most studied ingredient in this category. Pickart et al. (2015, Journal of Aging Science) documented its role in stimulating follicle size and prolonging the anagen phase in cell culture models. A small clinical study by Ley and colleagues (2020, Journal of Cosmetic Dermatology) found a statistically modest improvement in hair density with topical GHK-Cu formulations over 12 weeks, but the effect sizes were small and the control conditions weak. Kérastase Genesis contains edelweiss stem cells and aminexil, the latter of which has some peer-reviewed support. Paus et al. (2007, British Journal of Dermatology) showed aminexil may reduce collagen stiffening around the follicle, which theoretically prevents miniaturization. The honest summary: these ingredients have plausible mechanisms and preliminary positive signals, but no large randomized controlled trials show they match the effect size of minoxidil or finasteride for androgenic alopecia. The biology is real. The clinical magnitude at OTC doses is not yet established.

Where does the social media noise diverge from clinical reality?

The problem here isn't that the products are fraudulent. It's the framing. When a creator with 316,000 views uses language like "targets the hair follicle" and pairs it with hashtags pulling from injectable peptide therapy categories, the implied equivalency is misleading even if no explicit lie is told. GHK-Cu in an injectable form at therapeutic concentrations is a different clinical conversation than GHK-Cu in a rinse-off serum at an undisclosed percentage. The Ordinary does not disclose exact GHK-Cu concentration in their Multi-Peptide Serum. Without that number, claims about follicle-level targeting are speculative. Additionally, "density and fullness" as outcomes conflate cosmetic appearance (hair shaft swelling from conditioning agents) with actual follicle-level growth, which requires histological or trichoscopy confirmation. No TikTok product recommendation is delivering that data. The creator's vibe framing, specifically describing these products as "effective," is an efficacy claim that the available literature does not robustly support for these specific formulations.

What should you actually know?

If you have clinically significant hair thinning, topical peptide serums are not a replacement for a proper evaluation. Androgenic alopecia, telogen effluvium, and alopecia areata require different interventions, and none of them are reliably addressed by OTC serums alone. Minoxidil remains the most evidence-supported topical option with decades of RCT data behind it. That said, peptide-containing serums are generally low-risk, and for mild diffuse thinning or as adjuncts to evidence-based treatment, they are unlikely to cause harm. GHK-Cu specifically has a reasonable safety profile. The Ordinary's product is affordable enough that the cost-to-curiosity ratio is low. But anyone experiencing accelerated shedding, patchy loss, or scalp symptoms should see a dermatologist before spending money on any serum stack. A board-certified dermatologist or trichologist can order lab work, assess hormone panels, and rule out treatable systemic causes that a $15 serum will not fix.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Lalmaseli · TikTok creator

316.5K views on this video

1. The Ordinary Multi-Peptide Serum 🧪 • The Goal: Density & Fullness. • How it works: Uses advanced peptide technologies to target the hair follicle. • Best for: If your hair feels thin or you want to see more "mass" and volume. • The Vibe: Scientific, affordable, and effective. 2. Kérastase Genesis Sérum Anti-Chute 🛡️ • The Goal: Anti-Hair Fall & Strength. • How it works: Uses Aminexil and Ginger Root to reinforce the hair at the root and prevent breakage. • Best for: If your hair is shedding

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu (copper tripeptide-1) has real biological plausibility for hair follicle?

GHK-Cu (copper tripeptide-1) has real biological plausibility for hair follicle support, but clinical evidence from large RCTs is still missing for OTC topical formulations.

What does the video say about the ordinary does not disclose the concentration of ghk-cu in?

The Ordinary does not disclose the concentration of GHK-Cu in its Multi-Peptide Serum, making direct efficacy comparisons to studied doses impossible.

What does the video say about aminexil in kérastase genesis has modest peer-reviewed support for reducing?

Aminexil in Kérastase Genesis has modest peer-reviewed support for reducing follicle stiffening, but evidence is largely from small or industry-affiliated studies.

What does the video say about topical peptide serums?

Topical peptide serums are not equivalent to injectable peptide therapies like GHK-Cu in clinical protocols; delivery method and concentration change the entire pharmacological picture.

What does the video say about minoxidil remains the most evidence-supported topical hair loss treatment with?

Minoxidil remains the most evidence-supported topical hair loss treatment with decades of randomized controlled trial data behind it.

What does the video say about anyone experiencing accelerated shedding, patchy hair loss,?

Anyone experiencing accelerated shedding, patchy hair loss, or scalp inflammation should see a dermatologist before using any serum as a primary treatment.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Lalmaseli, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.